Previous 10 | Next 10 |
home / stock / rlftf / rlftf news
Acer Therapeutics buys Relief Therapeutics' stake in OLPRUVA™ worldwide, excluding geographical Europe, providing an upfront payment of $10 million in cash to Relief Therapeutics with the potential for an additional $46.5 million in milestone and royalty payments The transition from a...
Recent Pentech Health acquisition of ZOIA Pharma broadens distribution and access for patients to PKU GOLIKE ® GENEVA, SWITZERLAND / ACCESSWIRE / July 19, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief Therapeutics, or the Company), a biopharmaceu...
Ad hoc announcement pursuant to Art. 53 LR GENEVA, SWITZERLAND and DUBAI, UAE / ACCESSWIRE / June 23, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFFD )(OTCQB: RLFTD ) (Relief Therapeutics, or the Company), a biopharmaceutical company committed to delivering innovative treatm...
Ad hoc announcement pursuant to Art. 53 LR GENEVA, SWITZERLAND / ACCESSWIRE / June 23, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFFD )(OTCQB: RLFTD ) (Relief Therapeutics, or the Company), a biopharmaceutical company committed to delivering innovative treatment options wit...
GENEVA, SWITZERLAND / ACCESSWIRE / June 20, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) (Relief Therapeutics, or the Company), a biopharmaceutical company committed to delivering innovative treatment options with the potential for transformative outcomes to ...
Ad hoc announcement pursuant to Art. 53 LR GENEVA, SWITZERLAND / ACCESSWIRE / June 16, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFFD )(OTCQB: RLFTD ) (Relief Therapeutics, or the Company), a biopharmaceutical company committed to delivering innovative treatment options with...
GENEVA, SWITZERLAND / ACCESSWIRE / May 26, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFFD )(OTCQB: RLFTD ) (Relief Therapeutics, or the Company), a biopharmaceutical company committed to delivering innovative treatment options with the potential for transformative outcomes to b...
The state-of-the-art quality control and research and development laboratory in Balerna, Switzerland is run by APR Applied Pharma Research SA, a Relief Therapeutics subsidiary GENEVA, SWITZERLAND / ACCESSWIRE / May 15, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFFD )(OTCQB...
GENEVA / ACCESSWIRE / May 12, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFFD )(OTCQB: RLFTD ) (Relief Therapeutics, or the Company), a biopharmaceutical company committed to delivering innovative treatment options with the potential for transformative outcomes to benefit those ...
GENEVA, SWITZERLAND / ACCESSWIRE / May 3, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) (Relief Therapeutics), a biopharmaceutical company committed to delivering innovative treatment options with the potential for transformative outcomes to benefit those suff...
News, Short Squeeze, Breakout and More Instantly...
Mondobiotech Holding AG Basel Company Name:
RLFTF Stock Symbol:
OTCMKTS Market:
GENEVA, SWITZARLAND / ACCESSWIRE / April 30, 2024 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) (Relief), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today published its Annual Repo...
PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call p...
GENEVA, SWITZERLAND / ACCESSWIRE / March 22, 2024 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announce...